First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Stock Price Up 0% – Here’s Why

Posted by Casey Walker on Dec 28th, 2024

Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) were up 0% during mid-day trading on Friday . The company traded as high as GBX 1,629.64 ($20.51) and last traded at GBX 1,626.79 ($20.47). Approximately 8 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 1,655 shares. The stock had previously closed at GBX 1,626 ($20.46).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 0.0 %

The company has a current ratio of 9.42, a quick ratio of 9.27 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of £4.81 billion and a P/E ratio of -1,478.90. The stock’s 50-day simple moving average is GBX 1,639.41 and its 200-day simple moving average is GBX 1,573.32.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.